Nasdaq:US$15.41 (+0.36) | HKEX:HK$25.05 (+1.50) | AIM:£2.23 (-0.04)
News & Presentations
Previous Article   |   Next Article
Presentations, Scientific Publications | 14 Oct 2012

ISSX 2012: Pharmacokinetic/Pharmacodynamic Modeling of Epitinib to Evaluate the Anti-cancer Effect on A431 Tumor Xenograft in Nude Mice